Regenstrief Institute joined Indiana University and key bioscience organizations to establish the IU Launch Accelerator for Biosciences (IU LAB) at 16 Tech Innovation District. This initiative will drive advancements in human health, support commercialization efforts and position Indiana as a leader in bioscience innovation.
A launch event on Monday, January 27, 2025, brought together leaders from Regenstrief, Indiana University and partner organizations to celebrate this milestone.
The $138 million grant from Lilly Endowment will fund construction of a state-of-the-art facility for IU LAB that will integrate education, research and development, and business incubation and acceleration at the 16 Tech Innovation District.
In collaboration with some of the state’s key biosciences organizations — including IU, IU School of Medicine, 16 Tech, Central Indiana Corporate Partnership, BioCrossroads, Indiana Biosciences Research Institute, Regenstrief Institute and IU Health — IU LAB will drive advancements and commercialization in biosciences, as well as develop talent to support this dynamic sector.
Attendees of the event (pictured above) included Alan Palkowitz, PhD, president and CEO of Indiana Bioscience Research Institute; Pamela Whitten, PhD, president of Indiana University; Rachel Patzer, PhD, MPH, president and CEO of Regenstrief Institute; Emily Krueger, CEO and president of 16 Tech; Russ Mumper, PhD, vice president for research at Indiana University; Melina Kennedy, CEO of Central Indiana Corporate Partnership and David Rosenberg, president and CEO of IU LAB.
